Lumpkin M M, Smith T F, Coulam C B, O'Brien P C
Int J Fertil. 1987 Mar-Apr;32(2):122, 126-30.
Semen specimens from 24 donors in an artificial insemination program--selected for women whose infertile status was determined to be male factor-related and for whom no female factor could be determined--were cultured for the presence of Ureaplasma urealyticum. A life table statistical analysis indicated that conception did not occur sooner in the U. urealyticum-negative group (n = 14) compared with those women inseminated with the U. urealyticum-containing semen (n = 10). In addition, no significant differences were detected in semen analysis count, grade, or motility between semen with or without U. urealyticum. We found no differences in the occurrence of fetal morbidity or mortality in ten conceptions between the women impregnated with Ureaplasma-positive (n = 14) and Ureaplasma-negative (n = 6) semen. Thus, our study does not support the role of U. urealyticum as a cause of male factor-related infertility or early pregnancy loss.
在一项人工授精项目中,从24名供体采集精液样本——这些供体是为那些不育状况被确定与男性因素相关且无法确定存在女性因素的女性挑选的——培养以检测解脲脲原体的存在。生存表统计分析表明,与接受含解脲脲原体精液人工授精的女性(n = 10)相比,解脲脲原体阴性组(n = 14)的受孕并未更早发生。此外,无论精液中是否含有解脲脲原体,在精液分析的计数、等级或活力方面均未检测到显著差异。我们发现,接受解脲脲原体阳性精液(n = 14)和阴性精液(n = 6)的女性所怀的十次妊娠中,胎儿发病率或死亡率并无差异。因此,我们的研究不支持解脲脲原体作为男性因素相关不育或早期妊娠丢失原因的作用。